Abstract:The study by me and my colleagues our study in the May 2015 issue of Journal of Surgical Research compared the clinical efficacy and safety of radiofrequency ablation (RFA) versus surgical resection (SR) for intrahepatic hepatocellular carcinoma (HCC) recurrence using meta-analysis techniques [1]. We found that the 1-, 3-, 5-year overall survival rate and procedure-related mortality rate were similar in patients treated with RFA or SR. Meanwhile, SR was associated with significantly higher 1-, 3-, 5-year recurrencefree survival rate and procedure-related morbidity rate compared with RFA. Then, we concluded that RFA seems to be as effective as SR for the treatment of intrahepatic HCC recurrence owing to comparable overall survival benefits though RFA was associated with lower recurrence-free survival, and the advantages of being less invasive, highly target-selective and repeatable may render RFA a preferred treatment option for selected patients [2, 3]. Herein, we would like to raise the following comments: In our study, most of the included studies were performed in Asian countries where there is high prevalence of hepatitis B virus (HBV) related HCC; only one study was performed in non-Asian county country. It has been suggested that early HCC recurrence is generally considered as the dissemination of initial HCCs which were undetected by imaging modalities [2, 3]. Also, recent studies have demonstrated that high HBV load and HBV mutation promote the growth and metastasis of HCC, and the hepatitis B virus X protein promotes the invasive and metastatic potential of HCC [4, 5]. These viral factors may actually accelerate the recurrence of HCC after RFA rather than after surgical resection as due to the RFA’s insufficient elimination of the first recurrent HCC ablation feature of RFA in certain conditions compared to surgical resection. Therefore, whether the results, especially the recurrence-free survival outcomes, could be applicable to non-Asian populations remains to be determined. In addition, RFA can be performed via percutaneous, laparoscopic or open approaches, and percutaneous RFA is the most less least invasive approach and significantly improves the rate of censored patients compared to other approaches. However, in our study, we did not compare each of these three approaches with surgical resection for intrahepatic hepatocellular carcinoma recurrence. Therefore, the clinical efficacy and safety of different approaches of RFA versus surgical resection, especially RFA via percutaneous versus surgical resection, should be further researched.

Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma

Surgical Resection Plus Radiofrequency Ablation Versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Surgical Resection Plus Radiofrequency Ablation for the Treatment of Multifocal Hepatocellular Carcinoma.

A comparison of efficacy between radiofrequency ablation and surgical resection in treatment of small primary hepatocellular carcinoma

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

Comparative Effectiveness of Radiofrequency Ablation Vs. Surgical Resection for Patients with Solitary Hepatocellular Carcinoma Smaller Than 5 Cm

Prospective Comparative Study of Cool-Tip Radiofrequency Ablation and Surgical Resection for Hepatocellular Carcinoma

Radiofrequency Ablation is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size.

Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma: A Meta Analysis

Radiofrequency Ablation Versus Surgical Resection for Intrahepatic Hepatocellular Carcinoma Recurrence

Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan

Comparison Of Long-Term Effectiveness And Complications Of Radiofrequency Ablation With Hepatectomy For Small Hepatocellular Carcinoma

Radiofrequency Ablation Versus Surgical Resection for Intrahepatic Hepatocellular Carcinoma Recurrence: a Meta-Analysis

Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients

Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis.

The efficacy of radiofrequency ablation in treatment of hepatocellular carcinoma in aged patients

Radiofrequency Ablation Vs. Surgical Resection for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta‑analysis

A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices

Overall Survival Rates Become Similar Between Percutaneous Ablation and Hepatic Resection with Increasing Age among Elderly Patients with Early Hepatocellular Carcinoma.

Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies

Effectiveness and Safety of Radiofrequency Ablation versus Liver Resection in the Treatment of Early-stage Hepatocellular Carcinoma: A Systematic Review and Meta-analysis